BioTech & Life Sciences

TLDR

Belgium's biotech and life sciences sector is the country's top-funded vertical, with companies like SOPHiA GENETICS, AgomAb Therapeutics, and Flamingo Therapeutics raising $97M in 2025.

Overview

Belgian biotech benefits from a deep academic infrastructure anchored by KU Leuven, UGent, UCLouvain, and the VIB research institute. The sector spans oncology, rare diseases, genomics, and diagnostics, with a growing cluster of clinical-stage companies.

Key investors active in the sector include V-Bio Ventures, PMV (ParticipatieMaatschappij Vlaanderen), imec.xpand (for deep tech life sciences overlap), and QBIC (for university spin-offs). The upcoming Quantum Biospace campus in Walloon Brabant will add significant co-location infrastructure for the sector.

SOPHiA GENETICS stands out as the most internationally recognized Belgian biotech, having raised over $230M and built an AI-powered clinical genomics platform used by hospitals worldwide.